Discover Oncology, formerly Hormones and Cancer, is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a high level of author service at every stage. It is an open access, community-focussed journal publishing content that interfaces at all levels of cancer research.
  • We welcome research from across all fields relevant to oncology.

  • Our streamlined submission process ensures a swift turnaround time to publish your research rapidly while maintaining the highest peer-review standards.

  • As a fully open access journal, we ensure that your research is highly discoverable and instantly available globally to everyone.

  • We provide you with an excellent support service at every stage to guide you through the whole submission, review and publication process.

  • The Discover journals uphold the ethical standards for research and publication as defined by COPE, and support authors in adhering to these throughout the peer-review process.

Journal information

  • Eleonora Candi
Publishing model
Open Access. How to publish with us

Journal metrics

4.667 (2021)
Impact factor
3.607 (2021)
Five year impact factor
3 days
Submission to first decision (Median)
144,984 (2021)

Latest articles

Journal updates

  • Discover Oncology has an impact factor of 4.67

    Hormones and Cancer changed its title to Discover Oncology in 2021, and under the new title the journal continues to be included in the major indexing services it was previously (e.g. PubMed, Scopus, SCIE).

    For the journal's Impact Factor as calculated by Clarivate, the Web of Science Master List entry for Discover Oncology displays the Impact Factor as 4.67.

  • Hormones and Cancer is now Discover Oncology

    As of January 2021 Hormones and Cancer (eISSN: 1868-8500) has been relaunched as Discover Oncology (eISSN: 2730-6011), a fully open access journal covering all aspects of cancer research. As a fully open access journal, all content is published under a CC BY open access license, and freely available to readers worldwide, enabling the widest possible dissemination and reuse. All non-OA content published prior to the title change is now free-to-read. Find out more

  • Meet the Editor-in-Chief for Discover Oncology

    Learn more about our Editor-in-ChiefEIC-Oncology-Candi-websitehomethumb-198x112

  • Discounted APCs for launch content

    All articles published by Discover Oncology are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. 

View all updates

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more

About this journal

Electronic ISSN
Abstracted and indexed in
  2. Baidu
  3. Biological Abstracts
  5. CNKI
  7. Chemical Abstracts Service (CAS)
  8. DOAJ
  9. Dimensions
  10. EBSCO Discovery Service
  11. EMBASE
  12. Google Scholar
  13. INIS Atomindex
  14. Japanese Science and Technology Agency (JST)
  15. Journal Citation Reports/Science Edition
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Portico
  19. ProQuest-ExLibris Primo
  20. ProQuest-ExLibris Summon
  21. PubMedCentral
  22. Reaxys
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SCIE)
  26. Semantic Scholar
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
  29. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Science+Business Media, LLC